Immunotherapy With or Without Radiation Therapy for Metastatic Urothelial Cancer
Condition(s):Metastatic Urothelial Carcinoma; Platinum-Resistant Urothelial Carcinoma; Stage IV Bladder Cancer AJCC v8Last Updated:March 15, 2024Recruiting
Include Studies Not Open or Pending
Condition(s):Metastatic Urothelial Carcinoma; Platinum-Resistant Urothelial Carcinoma; Stage IV Bladder Cancer AJCC v8Last Updated:March 15, 2024Recruiting
Condition(s):Radiation Therapy; Bone Metastases; PainLast Updated:February 22, 2023Recruiting
Condition(s):Loco-regionally Recurrent NSCLC After Thoracic RadiotherapyLast Updated:February 21, 2020Recruiting
Condition(s):Hepatocellular Carcinoma Non-resectable; Portal Vein Tumor Thrombus; Immune Checkpoint InhibitorsLast Updated:September 15, 2023Recruiting
Condition(s):Non-small Cell Lung Cancer; Non-small Cell Carcinoma; Non-small Cell Lung Cancer Stage I; Non-small Cell Lung Cancer Stage II; Non-small Cell Lung Cancer Stage IIILast Updated:October 3, 2023Not yet recruiting
Condition(s):Non Small Cell Lung CancerLast Updated:January 27, 2023Recruiting
Condition(s):Lung Cancer; Left Sided Breast CancerLast Updated:January 23, 2024Recruiting
Condition(s):Hepatocellular Carcinoma; Resectable Hepatocellular CarcinomaLast Updated:March 15, 2023Recruiting
Condition(s):Brain Metastases; Radiotherapy; EGFR Activating MutationLast Updated:March 14, 2023Recruiting
Condition(s):SBRT; Radical ProstatectomyLast Updated:March 18, 2020Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.